内侧跟动脉超选择性栓塞:一种用于足底筋膜炎快速缓解疼痛的微创新方法
6个月时VAS评分从基线7.3±0.7降至1.3±0.5(p<0.001),FFI评分从55.5±4.9改善至20.4±6.3(p<0.001),足底筋膜厚度从5.2±0.6 mm降至3.7±0.3 mm(p<0.001),5例(15.6%)出现轻微复发。
要点
- 栓塞前需明确内侧跟动脉起源,96.9%起自胫后动脉或足底外侧动脉,3.1%因解剖变异起自腓动脉。
- 超声测量足底筋膜厚度可用于疗效随访,6个月时较基线下降(5.2±0.6 mm vs 3.7±0.3 mm,p<0.001)。
- 术后6个月VAS评分从7.3±0.7降至1.3±0.5(p<0.001),FFI从55.5±4.9改善至20.4±6.3(p<0.001)。
核心结论
- 采用亚胺培南/西司他丁行内侧跟动脉超选择性栓塞是慢性足底筋膜炎患者快速持久缓解疼痛的新型、安全、微创策略。
研究设计与样本
- 单中心前瞻性研究,纳入32例(女17例、男15例;平均年龄47.3±9.1岁)保守治疗无效的慢性足底筋膜炎患者,行内侧跟动脉超选择性栓塞,评估VAS、FFI及超声足底筋膜厚度。
关键影像表现/征象
- 31例(96.9%)内侧跟动脉起源于胫后动脉或足底外侧动脉,1例(3.1%)因解剖变异起源于腓动脉。
- 超声示足底筋膜厚度从基线5.2±0.6 mm降至6个月时3.7±0.3 mm(p<0.001)。
诊断标准与关键数值
- 疼痛采用视觉模拟量表(VAS)评估,基线7.3±0.7降至6个月1.3±0.5(p<0.001)。
- 功能采用足功能指数(FFI)评估,基线55.5±4.9改善至6个月20.4±6.3(p<0.001)。
- 全部手术技术成功,无主要或次要并发症。
- 5例(15.6%)从事体力要求高职业的患者出现轻微复发,建议使用矫形鞋垫,无需重复栓塞。
临床应用与阅片要点
- 术前需识别内侧跟动脉起源变异,尤其注意3.1%可起自腓动脉。
- 超声测量足底筋膜厚度可作为疗效随访的影像指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study evaluated the efficacy and safety of superselective embolization of the medial calcaneal artery using imipenem/cilastatin in patients with chronic, treatment-resistant plantar fasciitis.
MATERIALS AND METHODS: In this single-center prospective study, 32 patients (17 females, 15 males; mean age: 47.3 ± 9.1 years) with chronic plantar fasciitis unresponsive to conservative treatments underwent superselective embolization of the medial calcaneal artery using imipenem/cilastatin. In 31 patients (96.9 %), the target artery originated from the posterior tibial artery or lateral plantar artery; in one patient (3.1 %), it originated from the peroneal artery due to anatomical variations. Pain severity was assessed using the Visual Analog Scale (VAS), functional status with the Foot Function Index (FFI), and plantar fascia thickness using ultrasound imaging. Technical success, complications, and recurrence were recorded.
RESULTS: All procedures were technically successful, with no major or minor complications. The mean VAS score decreased from 7.3 ± 0.7 at baseline to 1.3 ± 0.5 at six months (p < 0.001), while the mean FFI score improved from 55.5 ± 4.9 to 20.4 ± 6.3 (p < 0.001). Plantar fascia thickness decreased from 5.2 ± 0.6 mm to 3.7 ± 0.3 mm at six months (p < 0.001). Minimal recurrence was observed in five patients (15.6 %) with physically demanding occupations and orthopedic heel insoles were recommended; however, no repeat embolization was required.
CONCLUSION: Superselective embolization of the medial calcaneal artery using imipenem/cilastatin represents a novel, safe, and minimally invasive strategy for rapid and sustained pain relief in patients with chronic plantar fasciitis.
引用
- Tonkaz M, Bekci T. Superselective embolization of the medial calcaneal artery: a minimally invasive and novel solution for rapid pain relief in plantar fasciitis. Eur J Radiol. 2025. PMID: 41317571. doi:10.1016/j.ejrad.2025.112573
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。